Navigation Links
Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
Date:5/31/2008

can Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network recommend the use of Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive. For more information about Oncotype DX, please visit http://www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(R), which has been shown to predict the likelihood chemotherapy benefit as well as recurrence in early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's belief that the results of these studies could lead to the development of new tests for predicting the benefit of certain targeted therapies used in the treatment of cancer. These risks and uncertainties include, but are not limited to: the results of additional clinical studies; the risk that we may not obtain sufficient levels of reimbursement for any future tests we may develop; our ability to develop and commercialize new products; the risks and uncertainties associated with the regulation of our tests by FDA; our ability to obtain c
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
2. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
5. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
6. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
7. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
8. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
11. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Decision Resources Group finds ... the U.S. Food and Drug Administration,s (FDA) approval of ... Velphoro, which was approved by the FDA in November ... disease (CKD) patients on dialysis. Other key ... (US) Q2 2014 : ...
(Date:1/15/2014)... 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced ... Global Industry Analysis, Size, Share, Growth, Trends And Forecast, ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... patients in order to treat dental impairments, for tooth ...
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
... The End of Polio Concert, funded by the ... 2011, in Perth Australia, has resulted in an unprecedented ... The highly publicized and critically acclaimed concert, which ... Polio Eradication Initiative, has resulted in contributions of $50 ...
... Conn., Nov. 7, 2011 Planet Biopharmaceuticals, Inc. and ... specialty pharmaceutical company focused on providing products for allergy ... an asset sale of ALLERGY CONTROL PRODUCTS, INC., a ... Jersey limited liability company. Theron E. Odlaug, ...
Cached Medicine Technology:Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 2Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 3Pioneering Gift From the Sumner M. Redstone Foundation Leads to $118 Million Multi-Country Commitment to End Polio 4
(Date:7/13/2014)... 2014 The Pearland, Texas location of The ... from four months to 12 years of age that offers ... birthday parties and Summer Camps, is now under new ownership. ... Pearland after spending over six years at The Little ... Director. , Berry has over ten years of experience ...
(Date:7/13/2014)... July 13, 2014 The federal court ... ) filed against Johnson & Johnson’s Ethicon, Inc. ... which is expected to get underway next month. According ... U.S. District Court, Southern District of West Virginia on ... on August 7, 2014 at 3:00 p.m. July selection ...
(Date:7/13/2014)... Max International has recently ... be the featured guest at its Charity Exhibition and ... Attendees will learn about Max’s health products and ... basketball games and perform in a 3 point shoot-out. ... and energy-boosting supplements , has recently announced former NBA ...
(Date:7/13/2014)... Fadhits.com is popular among worldwide women. Its lace ... Recently, the company has announced its new selection of ... all these outfits are available at discounted prices (from ... supplier is now offering similar discounts for many other ... many other designs for sale, including flower girl dresses, ...
(Date:7/13/2014)... ANGELES A noninvasive optical imaging device developed ... that later occur in the brain and are ... preliminary results from investigators conducting a clinical trial ... findings July 15 in an oral presentation at ... Denmark. They also were invited by conference organizers ...
Breaking Medicine News(10 mins):Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3
... -- Most children born with HIV infection now survive ... death that awaited HIV-infected babies years ago, researchers report. ... AIDS-causing virus, to better understand the effects of treatment ... these kids, at this point, don,t have virus detectable ...
... Associations for Dental Research (IADR/AADR) have published two studies ... income individuals. These articles, titled "Income-related Inequalities in Dental ... and "Income Inequality and Tooth Loss in the United ... in the Journal of Dental Research, the official publication ...
... By Dennis Thompson HealthDay Reporter , ... and the American Heart Association have put forth an ... attack, stroke and coronary heart disease. The goals ... and illness, however. They place even greater emphasis on ...
... Columbia Business School is proud to announce that Frank ... Finance and Economics and the Healthcare and Pharmaceutical Management ... by the Emerald Literati Network. The award recognizes an ... book series published by Emerald Group Publishing, a leading ...
... , FRIDAY, April 22 (HealthDay News) -- Lynne Braun spends a ... by their hearts and their health. Braun, who works as ... teaches at the university,s College of Nursing, helps counsel people who ... who,ve had a heart attack or stroke and hope to ...
... Healthcare today teleconferenced one of the world,s first live ... to conference attendees in Sao Paolo, Brazil. The meeting, ... of the globe,s largest vascular surgery events and includes ... an endograft device called a repositionable endoprosthesis. ...
Cached Medicine News:Health News:HIV Kids Growing Up Well, Study Finds 2Health News:IADR/AADR Journal of Dental Research releases studies on oral health inequalities in older people 2Health News:To Get Americans Healthier, U.S. Targets the Heart 2Health News:To Get Americans Healthier, U.S. Targets the Heart 3Health News:To Get Americans Healthier, U.S. Targets the Heart 4Health News:Columbia business school’s Frank Lichtenberg awarded by the Emerald Literati Network 2Health News:Nurse Practitioner Counsels Lifestyle Changes as Key to Heart Health 2Health News:Nurse Practitioner Counsels Lifestyle Changes as Key to Heart Health 3Health News:Scott & White Healthcare broadcasts live surgery to São Paolo, Brazil 2
... Maximum Xtra, and Maximum ACT introducers ... and specialty hemostasis introducers in the ... premier hemostasis introducers for use in ... angiography, angioplasty, stenting, atherectomy, temporary pacing, ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
The intended use of the percutaneous PREFACE Guiding Sheath is for the introduction of intravascular electrophysiology catheters into any cardiac chamber....
... EP Systems sells the popular transeptal ... needles. These products allow left atrial ... catheter ablation of left-sided arrhythmogenic substrates. ... others use it when a transaortic ...
Medicine Products: